COVID-19 in Children With Cancer: A Single Low-Middle Income Center Experience
- PMID: 33290293
- DOI: 10.1097/MPH.0000000000002025
COVID-19 in Children With Cancer: A Single Low-Middle Income Center Experience
Abstract
Background: Coronavirus disease-2019 (COVID-19) could be associated with morbidity and mortality in immunocompromised children.
Objective: The objective of this study was to measure the frequency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among hospitalized children with cancer and to detect the associated clinical manifestations and outcomes.
Methodology: A prospective noninterventional study including all hospitalized children with cancer conducted between mid-April and mid-June 2020 in Ain Shams University Hospital, Egypt. Clinical, laboratory, and radiologic data were collected. SARS-CoV-2 infection was diagnosed by reverse transcription polymerase chain reaction tests in nasopharyngeal swabs.
Results: Fifteen of 61 hospitalized children with cancer were diagnosed with SARS-CoV-2. Their mean age was 8.3±3.5 years. Initially, 10 (66.7%) were asymptomatic and 5 (33.3%) were symptomatic with fever and/or cough. Baseline laboratory tests other than SARS-CoV-2 reverse transcription polymerase chain reaction were not diagnostic; the mean absolute lymphocyte count was 8.7±2.4×109/L. C-reactive protein was mildly elevated in most of the patients. Imaging was performed in 10 (66.7%) patients with significant radiologic findings detected in 4 (40%) patients. Treatment was mainly supportive with antibiotics as per the febrile neutropenia protocol and local Children Hospital guidance for management of COVID-19 in children.
Conclusions: Pediatric cancer patients with COVID-19 were mainly asymptomatic or with mild symptoms. A high index of suspicion and regular screening with nasopharyngeal swab in asymptomatic hospitalized cancer patients is recommended.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Clinical Characteristics and Viral RNA Detection in Children With Coronavirus Disease 2019 in the Republic of Korea.JAMA Pediatr. 2021 Jan 1;175(1):73-80. doi: 10.1001/jamapediatrics.2020.3988. JAMA Pediatr. 2021. PMID: 32857112 Free PMC article.
-
Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients.J Med Virol. 2021 May;93(5):2932-2937. doi: 10.1002/jmv.26821. Epub 2021 Feb 9. J Med Virol. 2021. PMID: 33501645 Free PMC article.
-
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839. JAMA. 2020. PMID: 32648899 Review.
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
Cited by
-
Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.EClinicalMedicine. 2022 Feb;44:101287. doi: 10.1016/j.eclinm.2022.101287. Epub 2022 Feb 11. EClinicalMedicine. 2022. PMID: 35169689 Free PMC article.
-
COVID-19 outcomes in paediatric cancer: A large scale pooled meta-analysis of 984 cancer patients.Rev Med Virol. 2022 Sep;32(5):e2344. doi: 10.1002/rmv.2344. Epub 2022 Mar 5. Rev Med Virol. 2022. PMID: 35247015 Free PMC article.
-
Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP).Ann Hematol. 2022 Aug;101(8):1843-1851. doi: 10.1007/s00277-022-04884-x. Epub 2022 Jun 20. Ann Hematol. 2022. PMID: 35726104 Free PMC article.
-
Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.Front Microbiol. 2022 Aug 31;13:974205. doi: 10.3389/fmicb.2022.974205. eCollection 2022. Front Microbiol. 2022. PMID: 36118201 Free PMC article. Review.
-
Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country.Clin Lymphoma Myeloma Leuk. 2021 Nov;21(11):e853-e864. doi: 10.1016/j.clml.2021.07.025. Epub 2021 Jul 26. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34420893 Free PMC article.
References
-
- Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720.
-
- Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;58:712–713.
-
- Cai J, Xu J, Lin D, et al. Case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020;71:1547–1551.
-
- Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702.
-
- Ogimi C, Englund JA, Bradford MC, et al. Characteristics and outcomes of coronavirus infection in children: the role of viral factors and an immunocompromised state. J Pediatric Infect Dis Soc. 2019;8:21–28.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous